BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 11981910)

  • 1. Second trimester ultrasound screening for chromosomal abnormalities.
    Shipp TD; Benacerraf BR
    Prenat Diagn; 2002 Apr; 22(4):296-307. PubMed ID: 11981910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonographic scoring index for prenatal detection of chromosomal abnormalities.
    Benacerraf BR; Neuberg D; Bromley B; Frigoletto FD
    J Ultrasound Med; 1992 Sep; 11(9):449-58. PubMed ID: 1283415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit.
    Bottalico JN; Chen X; Tartaglia M; Rosario B; Yarabothu D; Nelson L
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):161-8. PubMed ID: 19173242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance of different methods of estimating risk screening for chromosomal anomalies].
    Avătăjitei MC; Moscalu M; Martiniuc V; Onofriescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):515-22. PubMed ID: 23077946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of ultrasound markers in screening fetal trisomy 21].
    Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The ultrasound markers of the aneuploid fetus in the first and second trimesters of pregnancy].
    Haimov-Kochman R; Yagel S
    Harefuah; 2001 Jun; 140(6):531-40. PubMed ID: 11420858
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the importance of second-trimester "soft markers" for trisomy 21 after an 11- to 14-week aneuploidy screening scan?
    Bromley B; Shipp TD; Lyons J; Groszmann Y; Navathe RS; Benacerraf BR
    J Ultrasound Med; 2014 Oct; 33(10):1747-52. PubMed ID: 25253820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21.
    Vintzileos AM; Campbell WA; Rodis JF; Guzman ER; Smulian JC; Knuppel RA
    Obstet Gynecol; 1996 Jun; 87(6):948-52. PubMed ID: 8649704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonographic markers of fetal trisomies: second trimester.
    Nyberg DA; Souter VL
    J Ultrasound Med; 2001 Jun; 20(6):655-74. PubMed ID: 11400940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
    Tercanli S; Holzgreve W; Batukan C; Gerber A; Ermis H; Miny P
    Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of second-trimester fetuses with autosomal trisomy by use of a sonographic scoring index.
    Benacerraf BR; Nadel A; Bromley B
    Radiology; 1994 Oct; 193(1):135-40. PubMed ID: 8090881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for chromosomal abnormalities by first trimester combined screening and noninvasive prenatal testing.
    Kagan KO; Hoopmann M; Hammer R; Stressig R; Kozlowski P
    Ultraschall Med; 2015 Feb; 36(1):40-6. PubMed ID: 25255236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of ultrasonography in second trimester screening for fetal chromosome aberrations].
    Papp C; Bán Z; Szigeti Z; Hajdú J; Beke A; Tóth-Pál E; Csaba A; Joó JG; Mezei G; Papp Z
    Orv Hetil; 2006 Nov; 147(44):2131-7. PubMed ID: 17209302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis for detection of aneuploidy: the options.
    Budorick NE; O'Boyle MK
    Radiol Clin North Am; 2003 Jul; 41(4):695-708. PubMed ID: 12899486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
    Spencer K; Spencer CE; Power M; Dawson C; Nicolaides KH
    BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for fetal aneuploidy.
    Rink BD; Norton ME
    Semin Perinatol; 2016 Feb; 40(1):35-43. PubMed ID: 26725144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of gestational age on the sonographic detection of aneuploidy.
    Picklesimer AH; Moise KJ; Wolfe HM
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1243-7. PubMed ID: 16157145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
    Benacerraf BR
    Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.